Raymond James & Associates Sells 3,112 Shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Raymond James & Associates trimmed its stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 6.2% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 47,257 shares of the company’s stock after selling 3,112 shares during the quarter. Raymond James & Associates owned approximately 0.47% of iShares U.S. Pharmaceuticals ETF worth $3,337,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of the stock. Janney Montgomery Scott LLC boosted its stake in shares of iShares U.S. Pharmaceuticals ETF by 3.0% during the 1st quarter. Janney Montgomery Scott LLC now owns 12,489 shares of the company’s stock worth $848,000 after acquiring an additional 358 shares during the period. &PARTNERS bought a new position in shares of iShares U.S. Pharmaceuticals ETF during the 2nd quarter worth approximately $267,000. Marshall Wace LLP bought a new position in shares of iShares U.S. Pharmaceuticals ETF during the 2nd quarter worth approximately $422,000. Texas Yale Capital Corp. boosted its stake in shares of iShares U.S. Pharmaceuticals ETF by 179.2% during the 1st quarter. Texas Yale Capital Corp. now owns 13,430 shares of the company’s stock worth $912,000 after acquiring an additional 8,620 shares during the period. Finally, Comerica Bank lifted its holdings in iShares U.S. Pharmaceuticals ETF by 71.6% during the 1st quarter. Comerica Bank now owns 1,462 shares of the company’s stock worth $99,000 after purchasing an additional 610 shares during the last quarter.

iShares U.S. Pharmaceuticals ETF Trading Down 0.2 %

NYSEARCA:IHE opened at $68.92 on Monday. The stock has a market cap of $696.09 million, a P/E ratio of 6.49 and a beta of 0.58. The stock has a 50 day simple moving average of $71.05 and a 200 day simple moving average of $68.28. iShares U.S. Pharmaceuticals ETF has a 1-year low of $56.03 and a 1-year high of $72.94.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.